Atlas Trials

Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment

Clinical trial NCT06590090 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06590090
Sponsor
XBiotech, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2026-07-15
Primary completion
2027-01-15
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.